checkAd
    Startseite > Aktien > InflaRx > Nachrichten
    InflaRx Aktie
    1,4630
     
    EUR
    -2,47 %
    -0,0370 EUR
    Letzter Kurs 08:03:39 Tradegate
    1,4530
     
    EUR
    1.500 STK
    Geldkurs 10:01:32
    1,4690
     
    EUR
    1.500 STK
    Briefkurs 10:01:32
    ISIN: NL0012661870 · WKN: A2H7A5 · SYM: IF0 · Niederlande

    Neueste Nachrichten

    InflaRx Hosts R&D Event Highlighting the Promise of INF904
    05.06.24 · globenewswire · InflaRx
    InflaRx Presents New Analysis of PANAMO Phase III Trial in Severe COVID-19 at ATS 2024 Showing Potential Synergy With Vilobelimab When Used in Combination with Other Immunomodulators
    21.05.24 · globenewswire · InflaRx
    InflaRx Reports First Quarter 2024 Financial Results and Provides Business Update
    08.05.24 · globenewswire · InflaRx
    InflaRx to Host Virtual R&D Event on June 5, 2024 and Report First Quarter 2024 Results on May 8, 2024
    30.04.24 · globenewswire · InflaRx
    InflaRx to Participate in Capital One Securities 1st Annual Biotech/Biopharma Disrupters Event
    24.04.24 · globenewswire · InflaRx
    Fokus Aktien mit extremen Handelsvolumen am Donnerstag, den 21.03.2024
    21.03.24 · wO Chartvergleich · ANZ Group Holdings
    InflaRx Reports Full Year 2023 Results and Announces INF904 Development Plans
    21.03.24 · globenewswire · InflaRx
    InflaRx to Announce Development Plans for INF904 and 2023 Financial Results on March 21, 2024
    19.03.24 · globenewswire · InflaRx
    InflaRx Appoints Jan Medina as Head of Investor Relations
    22.02.24 · globenewswire · InflaRx
    InflaRx Announces Initiation of its Commitment Program for GOHIBIC(vilobelimab) to Help Broaden Access for Eligible Patients
    25.01.24 · globenewswire · InflaRx
    InflaRx Announces Positive Topline Results from the Multiple Ascending Dose (MAD) Phase I Study with C5aR Inhibitor INF904
    04.01.24 · globenewswire · InflaRx
    Die größten Aufsteiger der Woche vom 13.12.-20.12.2023 in der wO Community
    20.12.23 · wO Chartvergleich · British American Tobacco